Announcements Trials
Browse Landscape

Status

Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 3

Sponsor

Cancer Type

Breast 3Gastrointestinal 1Classical hematology 1

Conditions

Breast Neoplasms 3Pancreatic Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Cancer, Papillary 1Myasthenia Gravis 1Kidney Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Glioblastoma 1Fanconi Anemia, Complementation Group D1 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Genotype × Clear all
NCT05755269 2026-05-01

Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

Mayo Clinic

Terminated
19 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05876728 2023-05-25

Role of Irisin/FNDC5 (rs3480) Single Nucleotide Polymorphism in Breast Cancer

Sohag University

Unknown
100 enrolled
Breast

Breast Neoplasms

NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Memorial Sloan Kettering Cancer Center

Withdrawn
BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡